Devonian Health Group Stock Performance
| DVHGF Stock | USD 4.27 0.00 0.00% |
Devonian Health holds a performance score of 12 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 95.0, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Devonian Health will likely underperform. Use Devonian Health information ratio, and the relationship between the coefficient of variation and skewness , to analyze future returns on Devonian Health.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Devonian Health Group are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating technical and fundamental indicators, Devonian Health reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 344.8 K | |
| Total Cashflows From Investing Activities | -5.1 M |
Devonian |
Devonian Health Relative Risk vs. Return Landscape
If you would invest 427.00 in Devonian Health Group on November 13, 2025 and sell it today you would earn a total of 0.00 from holding Devonian Health Group or generate 0.0% return on investment over 90 days. Devonian Health Group is currently producing 29.086% returns and takes up 179.5663% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Devonian, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Devonian Health Target Price Odds to finish over Current Price
The tendency of Devonian OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.27 | 90 days | 4.27 | about 42.93 |
Based on a normal probability distribution, the odds of Devonian Health to move above the current price in 90 days from now is about 42.93 (This Devonian Health Group probability density function shows the probability of Devonian OTC Stock to fall within a particular range of prices over 90 days) .
Devonian Health Price Density |
| Price |
Predictive Modules for Devonian Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Devonian Health Group. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Devonian Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Devonian Health is not an exception. The market had few large corrections towards the Devonian Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Devonian Health Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Devonian Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 168.12 | |
β | Beta against Dow Jones | 95.00 | |
σ | Overall volatility | 0.73 | |
Ir | Information ratio | 0.17 |
Devonian Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Devonian Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Devonian Health Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Devonian Health is way too risky over 90 days horizon | |
| Devonian Health appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 2.31 M. Net Loss for the year was (3.45 M) with profit before overhead, payroll, taxes, and interest of 561.01 K. | |
| Devonian Health Group has accumulated about 9.49 M in cash with (2.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07. |
Devonian Health Fundamentals Growth
Devonian OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Devonian Health, and Devonian Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Devonian OTC Stock performance.
| Return On Equity | -0.33 | |||
| Return On Asset | -0.12 | |||
| Profit Margin | (1.67) % | |||
| Operating Margin | (1.48) % | |||
| Current Valuation | 42.9 M | |||
| Shares Outstanding | 134.69 M | |||
| Price To Book | 2.75 X | |||
| Price To Sales | 19.73 X | |||
| Revenue | 2.31 M | |||
| EBITDA | (1.65 M) | |||
| Cash And Equivalents | 9.49 M | |||
| Cash Per Share | 0.07 X | |||
| Total Debt | 4.26 M | |||
| Debt To Equity | 0.31 % | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (2.87 M) | |||
| Total Asset | 21.59 M | |||
About Devonian Health Performance
By analyzing Devonian Health's fundamental ratios, stakeholders can gain valuable insights into Devonian Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Devonian Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Devonian Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Devonian Health Group Inc. engages in the development of botanical drugs. The company was incorporated in 2015 and is headquartered in Qubec, Canada. Devonian Health is traded on OTC Exchange in the United States.Things to note about Devonian Health Group performance evaluation
Checking the ongoing alerts about Devonian Health for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Devonian Health Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Devonian Health is way too risky over 90 days horizon | |
| Devonian Health appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 2.31 M. Net Loss for the year was (3.45 M) with profit before overhead, payroll, taxes, and interest of 561.01 K. | |
| Devonian Health Group has accumulated about 9.49 M in cash with (2.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07. |
- Analyzing Devonian Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Devonian Health's stock is overvalued or undervalued compared to its peers.
- Examining Devonian Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Devonian Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Devonian Health's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Devonian Health's otc stock. These opinions can provide insight into Devonian Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Devonian OTC Stock analysis
When running Devonian Health's price analysis, check to measure Devonian Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devonian Health is operating at the current time. Most of Devonian Health's value examination focuses on studying past and present price action to predict the probability of Devonian Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devonian Health's price. Additionally, you may evaluate how the addition of Devonian Health to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |